Adalimumab-ryvk
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications
Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN).
Journal: Rheumatology and therapy
Published: February 18, 2026
Showing 1-1 of 1
Last Updated: 04/28/2026